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Chemistry, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WisconsinABSTRACT The turnover of integral membrane proteins requires a specialized transport pathway mediated by components of
the endosomal sorting complex required for transport (ESCRT) machinery. In most cases, entry into this pathway requires that
cargoes undergo ubiquitin-modification, thereby facilitating their sequestration on endosomal membranes by specific, ubiquitin-
binding ESCRT subunits. However, requirements underlying initial cargo recognition of mono-ubiquitinated cargos remain
poorly defined. In this study, we determine the capability of each ESCRT complex that harbors a ubiquitin-binding domain to
bind a reconstituted integral membrane cargo (VAMP2), which has been covalently linked to mono-ubiquitin. We demonstrate
that ESCRT-0, but not ESCRT-I or ESCRT-II, is able to associate stably with the mono-ubiquitinated cargo within a lipid bilayer.
Moreover, we show that the ubiquitin-binding domains in both Hrs and STAM must be intact to enable cargo binding. These re-
sults indicate that the two subunits of ESCRT-0 function together to bind and sequester cargoes for downstream sorting into
intralumenal vesicles.INTRODUCTIONThe ESCRT machinery is composed of five multisubunit
complexes (ESCRT-0, ESCRT-I, ESCRT-II, ESCRT-III,
and the Vps4 complex) and several accessory proteins
(1–3). A majority of these factors are conserved among
eukaryotic species, suggesting that they play key roles in
regulating cellular function (4). Consistent with this idea,
ESCRT components have been implicated in a number of
membrane scission events, including intralumenal vesicle
(ILV) biogenesis on endosomes, cytokinetic abscission
to separate daughter cells after division, and the budding
of many retroviruses from the plasma membrane (5–7). In
each case, adaptors recruit ESCRT complexes that ulti-
mately bend and/or cleave the lipid bilayer. For example,
in mammalian cells, Cep55 recruits the ESCRT-I complex
to the site of abscission, whereas viral Gag isoforms bring
ESCRT-I to sites of virus budding on the plasma membrane
(8,9). Accumulation of ESCRT-I and other downstream
complexes on endosomal membranes depends on ESCRT-
0, which assembles as a heterotetramer of two unique sub-
units, Hrs and STAM, on lipid bilayers (10–12). In addition
to its role as an adaptor for ESCRT-mediated ILV formation,
ESCRT-0 also plays an important role in promoting ubiqui-
tin-dependent cargo sorting by virtue of its ability to bind
directly to ubiquitin (13–15). Both ESCRT-I and ESCRT-
II also harbor domains that associate with ubiquitin, raising
the possibility that multiple complexes in the ESCRT ma-
chinery participate in cargo recognition before depositionSubmitted March 25, 2014, and accepted for publication November 5, 2014.
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0006-3495/15/01/0076/9 $2.00into ILVs (1–3). However, the individual roles of these
ESCRT complexes in promoting cargo sequestration remain
ill-defined.
The ubiquitin-interacting domains found within subunits
of the early-acting ESCRT complexes (ESCRT-0, ESCRT-
I, and ESCRT-II) have been demonstrated to bind ubiquitin
weakly in solution, with affinities ranging from ~100 to
600 mM (2). The membrane-associated heterotetrameric
ESCRT-0 complex harbors at least eight ubiquitin-binding
surfaces, all of which can engage ubiquitin simultaneously
(12). In contrast, ESCRT-I contains no more than two do-
mains capable of interacting with ubiquitin (depending on
the presence of mammalian UBAP1 in the complex), and
ESCRT-II contains only a single ubiquitin-binding surface
(16–19). Although all early-acting ESCRT complexes
exhibit the ability to bind to endosomally enriched phospha-
tidylinositol 3-phosphate (PI3P), their affinities vary signifi-
cantly. At steady state, only ESCRT-0 accumulates stably on
endosomes, whereas ESCRT-I and ESCRT-II exhibit a more
transient association (2). Current evidence suggests that
ESCRT-0 recruits ESCRT-I, which in turn brings ESCRT-II
onto the membrane. These data suggest that a supercomplex
of the early-acting ESCRTmachinery may form to sequester
cargoes (13). However, assembly of such a higher-order olig-
omer is unlikely to be stable, as the distributions of each com-
plex have been shown to differ in vivo (10).
Recently, the ESCRT-0 complex, but not ESCRT-I, was
shown to accumulate at sites of clathrin-mediated endocytosis
at the plasma membrane, through its ability to interact
with a set of clathrin adaptors (20). In the absence of this
pool of ESCRT-0, ubiquitin-modified cargoes continue to behttp://dx.doi.org/10.1016/j.bpj.2014.11.004
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somal trafficking. These findings highlight the possibility that
initial recognition and/or sequestration of cargoes by ESCRT-
0 in clathrin-coated pits accelerates their downstream sorting
into ILVs. Similarly, ubiquitin-modified biosynthetic cargoes
leaving the trans-Golgi network encounter a pool of ESCRT-
0 on early endosomes, whichmay result in their local concen-
tration before endosome maturation and the accompanying
recruitment of downstream ESCRT complexes (1). In both
of these models, cargo sequestration depends on ESCRT-0,
whereas other ESCRTcomponents function to promotemem-
brane bending and scission (21).
To directly test the ability of early-acting ESCRT com-
plexes to bind cargo within a lipid bilayer, we developed a
system to measure the distribution of a mono-ubiquitin-con-
jugated substrate at nanometer-scale resolution using atomic
force microscopy (AFM). Importantly, in contrast to earlier
studies that used modified lipid headgroups to tether ubiqui-
tin to the surface of a bilayer (22), we took advantage of a
reconstituted integral membrane, mono-ubiquitin-modified
protein (VAMP2). We demonstrate that ESCRT-0, but not
ESCRT-I or ESCRT-II, is capable of binding this model
cargo stably, in a ubiquitin-dependent manner. Moreover,
we show that ubiquitin-binding domains in both subunits
of ESCRT-0 are critical for this effect, indicating that Hrs
and STAM function synergistically in this process. Our
data define the minimal number of lipid binding modules
that must function simultaneously to restrict cargo diffusion
within a physiologically relevant lipid bilayer.MATERIALS AND METHODS
Recombinant protein purification
Cloning and polycistronic co-expression of wildtype and mutant C. elegans
ESCRT-0, ESCRT-I, and ESCRT-II was conducted as described previously
(12,23,24). Briefly, to enable purification of each ESCRT complex, a poly-
histidine tag was appended onto the amino-terminus of a single subunit to
enable capture using nickel affinity chromatography.All complexeswere pu-
rified further using size exclusion chromatography. Purification of murine
VAMP2 or an amino-terminal translational fusion between ubiquitin and
VAMP2 was conducted as described previously (25). Briefly, bacterial pel-
lets were lysed by sonication and supplemented with ~1% Triton X-100
before binding to nickel affinity resin. Proteins were washed and eluted in
the presence of 1% n-octylglucoside, to maintain solubility. Purifications
of glutathione S-transferase (GST) and GST fusions to mono- and di-ubiqui-
tin were carried out using glutathione agarose beads. The immobilized GST
proteins were subjected to extensive washing using 20 mM Tris (pH 7.5),
500 mM NaCl, 0.1% Tween 20, 1 mM PMSF, and 1 mM DTT before a 30-
min incubation with purified ESCRT-0, ESCRT-I, or ESCRT-II. Subsequent
to the binding reaction, beads were washed five times using 20 mMTris (pH
7.5) and 150 mM NaCl and then eluted using 50 mM Tris (pH 7.5), 10 mM
glutathione, and 150 mM NaCl. Antibodies directed against Hrs, STAM,
Mvb12, and Vps22 have been described previously (12,20,23).Reconstitution of VAMP2 into liposomes
Phosphatidylcholine (PC), phosphatidylethanolamine (PE), and phosphati-
dylserine (PS) were obtained as chloroform solutions from Avanti PolarLipids (Alabaster, AL). Phosphatidylinositol 3-phosphate (PI3P) was ob-
tained as a solution in chloroform/methanol/water (1:2:0.8) from Echelon
Biosciences (Salt Lake City, UT). A lipid mixture of composition 54%
PC, 30% PE, 15% PS, and 1% PI3P was produced, and the solvents were
evaporated in a stream of nitrogen gas. Dried lipid (400 mg) was resus-
pended in 200 mL of 2% CHAPS in HEPES-buffered saline (HBS;
100 mM NaCl, 20 mM HEPES, pH 7.5), containing 1 mg of protein
(VAMP2 or ubiquitin-conjugated VAMP2). The mixture was then dialyzed
against 1 L of HBS for 3 days at 4C.Atomic force microscopy
Liposomes (either with or without integrated protein) were mixed with in-
dividual ESCRT complexes (final concentration of 150 nM in each case)
and incubated for 30 min at 37C. The suspension was then adsorbed
onto freshly cleaved mica for 3 min at room temperature. Imaging was per-
formed in tapping mode under fluid (HBS) using a Bruker Multimode in-
strument (Santa Barbara, CA), controlled by a Nanoscope IIIa controller,
at room temperature. Cantilevers (MikroMasch HQ:NSC18/AL BS, Inno-
vative Solutions Bulgaria, Sofia, Bulgaria) were tuned to between 10% to
20% below the peak of the resonance frequency, generally found between
25 and 35 kHz in fluid conditions (12,24). During the approach, the canti-
lever was set at 0.9 of free amplitude. During imaging, the set point value
was kept as high as possible so that the applied force was minimized. Im-
ages were captured at a scan rate of 2 Hz (unless otherwise noted), and with
512 scan lines per area. At least four cantilevers were used to generate each
volume distribution. Data analysis was performed using commercially
available software (NanoScope III software; Digital Instruments, Santa
Barbara, CA). Free-standing particles were identified. Particle heights
and diameters were measured manually by the Nanoscope software and
used to calculate the molecular volume of each particle using the following
equation:
Vm ¼ ðph=6Þ

3r2 þ h2; (1)
where h is the particle height and r the radius (25). This equation assumes
that the adsorbed particles adopt the form of a spherical cap. Asymmetricparticles, and particles at the bilayer edges, were excluded from the volume
analysis. More than 200 particles, from two to three independent experi-
ments, were analyzed for each condition.
To check that there were no systematic errors in measurement of h and r,
which could skew the determination of volumes, we constructed scatter
plots of h against particle diameter for the various particles imaged. These
are shown in Supporting Material. In all cases there was no strong correla-
tion between h and diameter, excluding the possibility of systematic errors.RESULTS
An AFM-based assay to study the distribution of
an integral membrane, ubiquitin-modified cargo
The ESCRT machinery mediates the ubiquitin-dependent
turnover of integral membrane cargoes in the endolysoso-
mal system. Previous work indicates that the translation
fusion of monoubiquitin to a transmembrane protein results
in its recognition by the ESCRT machinery and degradation
within the lysosome lumen (17). We sought to capitalize on
this finding and develop a model cargo that could be repro-
ducibly reconstituted into a lipid bilayer and visualized
without the use of conjugated dyes or other tags, which
might influence associations with binding partners. AFM af-
fords label-free imaging of proteins and protein complexBiophysical Journal 108(1) 76–84
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generate bilayers that mimic the surface of early endosomes
(26), we adsorbed liposomes composed of 54% PC, 30%
PE, 15% PS, and 1% PI3P onto mica. Imaging of protein-
free bilayers by AFM revealed a relatively homogenous sur-
face, with occasional gaps that exposed the underlying mica
(Fig. 1 A), as observed previously (12,24). Importantly, the
supported membrane exhibited a highly uniform thickness
of ~4 nm, consistent with the formation of a single lipid
bilayer.
Previous studies indicate that transmembrane proteins
in the soluble NSF attachment protein receptor (SNARE)
family are amenable to recombinant expression and recon-FIGURE 1 AFM imaging of VAMP2 and ubiquitin-VAMP2 integrated
into supported lipid bilayers. (A) Representative AFM image of a supported
lipid bilayer assembled in the absence of protein. A shade-height scale bar
is shown on the right of the image. Scale bar ¼ 200 nm. (B) Reconstituted
liposomes containing 1 mg of either VAMP2 or Ub-VAMP2 were floated
through an Accudenz density gradient and collected at the top by hand. Pro-
teins were then analyzed by SDS-PAGE (left). Similar amounts of protein
were recovered in each case, as determined by Coomassie staining. In
contrast, we failed to recover VAMP2 or Ub-VAMP2 from other regions
of the gradient, indicating that they had been efficiently incorporated into
liposomes (right). The molecular mass markers are indicated by dashes
on the right. From top to bottom, the markers have masses of 250, 150,
100, 75, 50, 37, 25, 20, and 10 kDa. (C) Representative AFM image of
a supported lipid bilayer assembled using liposomes containing VAMP2.
Protein-lined pores and protein-free pores are indicated by arrows and as-
terisks, respectively. (D) Upper panel, zoomed image of a bilayer region
containing a protein-lined pore and a free-standing particle. Lower panel,
a section through the bilayer at the position indicated by the line in the up-
per panel is shown. Note that the edges of the pore and the free-standing
particle protrude above the bilayer by ~0.5 nm. (E) Frequency distribution
of molecular volumes of VAMP2 particles in the bilayer. (F) Representative
AFM image of a supported lipid bilayer assembled using liposomes con-
taining ubiquitin-VAMP2. (G) Frequency distribution of molecular vol-
umes of ubiquitin-VAMP2 particles in the bilayer.
Biophysical Journal 108(1) 76–84stitution into synthetic liposomes (27). We purified a recom-
binant form of murine VAMP2 and used detergent (1%
n-octylglucoside) to maintain its solubility in solution. By
dialyzing away the detergent in the presence of phospho-
lipids, we were able to achieve spontaneous insertion of
VAMP2 into membranes. To verify incorporation, we con-
ducted a co-flotation assay, in which reconstituted vesicles
were mixed with Accudenz density medium and overlaid
with decreasing concentrations of Accudenz. After centrifu-
gation, vesicles floated to the top of the gradient and were
collected for analysis by SDS-PAGE. We found that
VAMP2 efficiently floated with vesicles in this assay, indi-
cating that VAMP2 was membrane-embedded (Fig. 1 B).
Fractions from elsewhere in the gradient were devoid of
protein (Fig. 1 B).
Next, VAMP2-containing liposomes were adsorbed onto
freshly cleaved mica for imaging. Numerous free-standing
particles were observed in the VAMP2-containing bilayers
(Fig. 1 C). In addition, VAMP2 induced the formation of
small pores in the bilayer (Fig. 1 C, arrows). These pores
had raised edges, suggesting that they were lined with pro-
tein, unlike the larger gaps in the bilayer (Fig. 1 C, aster-
isks), which were also observed in the absence of VAMP2
(Fig. 1 A). A zoomed image of a section of bilayer contain-
ing both a protein-lined pore and a free-standing particle is
shown in Fig. 1 D. Our subsequent analysis focused on the
free-standing particles only. These particles exhibited a
random distribution and had a peak molecular volume of
50 to 75 nm3 (Fig. 1 E). Given that the expected molecular
volume of VAMP2, based on its amino acid composition, is
16 nm3, we estimate that a typical particle contains three or
four VAMP2 molecules.
We should point out caveats associated with the measure-
ment of molecular volumes by AFM. For instance, it is
well known that the geometry of the scanning AFM probe
introduces a tendency to overestimate particle radii, a
convolution that becomes especially significant when imag-
ing under fluid, because fluid-imaging tips are blunter than
air-imaging tips. In addition, volume measurements of
particles bound to lipid bilayers do not take into account
any penetration of the bilayer by the protein, or any squash-
ing of the protein or the lipid by the tip. For this reason,
we regard the measured volumes as estimates rather than
precise values. Nevertheless, the reasonably close corre-
spondence seen in this study between the measured and ex-
pected volumes gives us confidence that our interpretation
of the imaging data is correct.
We translationally fused ubiquitin to the amino-terminus
of VAMP2 and purified the recombinant protein identically
to the wildtype form. Importantly, the efficiency of reconsti-
tuting ubiquitin-modified VAMP2 (Ub-VAMP2) into lipo-
somes was similar with that of unmodified VAMP2 (Fig. 1
B). The protein:lipid ratio of the liposomes was ~1:400
(w/w). Following assembly of supported lipid bilayers, we
found that Ub-VAMP2 continued to distribute randomly,
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rows). The only difference detected between Ub-VAMP2
and wildtype VAMP2 was an increase in its molecular vol-
ume to 75 to 125 nm3 (Fig. 1 G). The addition of a ubiquitin
moiety should increase the molecular volume of a VAMP2
molecule to 27 nm3. Hence, a typical particle again would
contain three or four Ub-VAMP2 molecules. Together, these
findings indicated that Ub-VAMP2 met all of our criteria for
determining whether components of the ESCRT machinery
can influence cargo distribution within a membrane. Addi-
tionally, parallel analysis of unmodified VAMP2 provided
an ideal control for all studies.FIGURE 2 Mutations in the ubiquitin-binding domains of ESCRT-0 do
not affect its assembly on lipid bilayers. (A, C, E, and G) Representative
AFM images of bilayers assembled in the presence of wildtype ESCRT-
0 (A), ESCRT-0 harboring point mutations in the DUIM domain of Hrs
(C), ESCRT-0 harboring two-point mutations in the VHS and UIM domains
of STAM (E), and ESCRT-0 harboring point mutations in all ubiquitin-
binding domains (G). A shade-height scale bar is shown. Scale bar ¼
200 nm. In panel B, a representative Coomassie stained gel of recombinant,
wildtype ESCRT-0 is also shown. The molecular mass markers are indi-
cated by dashes on the right. From top to bottom, the markers have masses
of 250, 150, 100, 75, 50, 37, 25, 20, and 10 kDa. Hrs and STAM are high-
lighted, as are two contaminants (asterisks), shown previously to be heat
shock proteins that do not bind to lipid bilayers (12). (B, D, F, and H)
The frequency distributions of molecular volumes for particles observed
by AFM are shown. Each graph indicates the form of ESCRT-0 visualized.
Arrows indicate the volume peaks corresponding to heterodimers and het-
erotetramers of Hrs and STAM.Ubiquitin-binding domains in both Hrs and STAM
are required for cargo binding
Previous work suggests that the ESCRT-0 complex acts up-
stream of other ESCRT components during the sorting of
ubiquitin-modified cargoes (2). ESCRT-0 is composed of
two subunits, Hrs and STAM, both of which contain at least
two ubiquitin-binding domains with affinities ranging from
~130 to 550 mM (12). Our goal was to determine whether
these low-affinity ubiquitin-binding domains could facilitate
the stable recruitment of an integral membrane protein in a
ubiquitin-dependent manner. We first confirmed that recom-
binant ESCRT-0, assembled using C. elegans Hrs and
STAM, bound to supported lipid bilayers composed of
54% PC, 30% PE, 15% PS, and 1% PI3P and in the absence
of VAMP2. Consistent with our previous work (12), we
found that individual particles of ESCRT-0 were distributed
evenly across the bilayer (Fig. 2 A). Analysis of their vol-
umes highlighted two major peaks, at 125 to 150 nm3 and
225 to 275 nm3, as indicated by the arrows in Fig. 2 B).
The expected volume of a heterodimer of Hrs and STAM,
based on the amino acid compositions of the two proteins,
is 162 nm3. We conclude, therefore, that the two volume
peaks correspond to heterodimers and heterotetramers of
Hrs and STAM. We next examined mutant ESCRT-0 com-
plexes, which harbor point mutations that impair the ability
of either Hrs or STAM (or both) to associate with ubiquitin
(12). Mutation of the DUIM (double ubiquitin interacting
motif) within Hrs did not affect particle size or particle
volume distribution as compared with wildtype ESCRT-
0 (Fig. 2, C and D). Similarly, point mutations in the
Vps27/Hrs/STAM (VHS) (W29A) and UIM domains of
STAM failed to affect the assembly of ESCRT-0 on lipid bi-
layers, either alone or in combination with mutations in the
Hrs DUIM domain (Fig. 2, E–H). Importantly, these data
highlight that both wildtype andmutant ESCRT-0 complexes
exhibit similar volume distributions, which are distinct from
those calculated for VAMP2 and Ub-VAMP2.
To assess whether ESCRT-0 could interact with an inte-
gral membrane cargo in bilayers, we compared the volume
distributions for ESCRT-0 and VAMP2 imaged together
with the distributions for the proteins imaged separately.We reasoned that if the proteins do not interact, then the
combined volume distribution will simply be an overlay
of the distributions of the two proteins imaged separately.
In contrast, if the two proteins interact on the bilayer, then
additional, larger particles will appear in the distribution.
We first incubated either wildtype or mutant ESCRT-0 com-
plexes with supported lipid bilayers containing unmodified
VAMP2 and determined the volumes of all particles
observed in an unbiased manner. When compared with theBiophysical Journal 108(1) 76–84
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we found that co-incubation of ESCRT-0 and VAMP2
reduced the frequency of particles exhibiting a volume be-
tween 100 to 300 nm3 (heterodimers and heterotetramers
of Hrs and STAM), whereas the number of particles with
a volume below 100 nm3 (VAMP2 alone) increased
(Fig. 3, A and B). We also examined mutant forms of
ESCRT-0, which contain mutations within its ubiquitin
binding domains, and obtained similar results (Fig. 3,
C–H). Together, these data strongly suggest that ESCRT-
0 does not bind to VAMP2.
In contrast to studies using unmodified VAMP2, we
observed a striking redistribution of particle volumes
when we co-incubated wildtype ESCRT-0 with Ub-
VAMP2 (Fig. 4, A and B). In particular, we found thatFIGURE 3 ESCRT-0 does not associate stably with VAMP2. (A, C, E,
and G) Representative AFM images of bilayers assembled in the presence
of VAMP2 and either (A) wildtype ESCRT-0, (C) ESCRT-0 harboring point
mutations in the DUIM domain of Hrs, (E) ESCRT-0 harboring two-point
mutations in the VHS and UIM domains of STAM, or (G) ESCRT-
0 harboring point mutations in all ubiquitin-binding domains. A shade-
height scale bar is shown. Scale bar ¼ 200 nm. (B, D, F, and H) The
frequency distributions of molecular volumes for particles observed by
AFM are shown. Each graph indicates the form of ESCRT-0 visualized
together with VAMP2.
Biophysical Journal 108(1) 76–84the frequency of particles exhibiting a volume larger than
300 nm3 (larger than ESCRT-0 heterotetramers or Ub-
VAMP2) increased dramatically as compared with wildtype
ESCRT-0 alone. These data strongly suggest that ESCRT-
0 binds directly to Ub-VAMP2 in lipid bilayers to form
stable complexes.
To determine whether the association between ESCRT-
0 and Ub-VAMP2 was dependent on the presence of its
multiple ubiquitin binding domains, we took advantage of
ESCRT-0 complexes harboring point mutations in the Hrs
DUIM domain, the STAM VHS domain, and the STAM
UIM domain. The DUIM domain of Hrs exhibits the stron-
gest affinity for ubiquitin (~130 mM) (12). In contrast to the
wildtype complex, ESCRT-0 harboring point mutations in
the DUIM domain of Hrs failed to promote the formation
of enlarged particles when mixed with Ub-VAMP2
(Fig. 4, C and D). These data indicate that the capture of
monoubiquitin-modified cargoes by ESCRT-0 requires the
DUIM domain of Hrs. We also tested the impact of muta-
tions in the VHS and UIM domains of STAM, which exhibit
affinities of ~280 and 550 mM for monoubiquitin, respec-
tively (12). Interestingly, the mutant complex was not able
to bind stably to Ub-VAMP2, as reflected by the absence
of particles larger than 300 nm3 (Fig. 4, E and F). As ex-
pected, based on these data, mutant ESCRT-0 harboring mu-
tations in all ubiquitin-binding sites also failed to bind to
Ub-VAMP2 (Fig. 4, G and H). Taken together, these data
indicate that ubiquitin binding sites in Hrs and STAM func-
tion together to facilitate stable, ubiquitin-dependent cargo
binding.ESCRT-I and ESCRT-II bind to immobilized
ubiquitin but are unable to stably associate with
an integral membrane, ubiquitin-modified
substrate
In addition to regulating ubiquitin-dependent trafficking to
the lysosome, ESCRT-0 also recruits the ESCRT-I complex
to endosomal membranes. ESCRT-I is composed of four
distinct subunits, which co-assemble with a 1:1:1:1 stoichi-
ometry (2). The combined molecular mass of the complex is
126 kDa, giving an expected molecular volume of 153 nm3.
In all organisms, including C. elegans, at least one subunit
of the complex harbors a ubiquitin-binding domain
(Tsg101). Although ESCRT-I binds only weakly to mem-
branes (2), we were able to visualize its accumulation by
AFM, even in the absence of ESCRT-0 (Fig. 5 A). We found
that ESCRT-I exhibited a peak molecular volume of ~150 to
200 nm3 when imaged on a membrane surface (Fig. 5 B).
These data are consistent with the formation of a 1:1:1:1
heterotetramer and indicate that ESCRT-I does not undergo
further oligomerization when bound to a lipid bilayer. Upon
addition of ESCRT-I to bilayers containing VAMP2,
we observed a downward shift in the particle volume distri-
bution, indicating that VAMP2 did not bind to ESCRT-I
FIGURE 5 ESCRT-I does not associate stably with VAMP2 or ubiquitin-
conjugated VAMP2. (A, C, and E) Representative AFM images of bilayers
assembled in the presence of either (A) ESCRT-I alone, (C) ESCRT-I
together with VAMP2, or (E) ESCRT-I together with Ub-VAMP2. A
shade-height scale bar is shown. Scale bar¼ 200 nm. (B, D, and F) The fre-
quency distributions of molecular volumes for particles observed by AFM
are shown. Each graph indicates the proteins present in the experiment. In
panel B, a representative Coomassie stained gel of recombinant ESCRT-I is
also shown. The molecular mass markers are indicated by dashes on the
right. From top to bottom, the markers have masses of 50, 37, 25, and
20, and 10 kDa. The ESCRT-I components, Tsg101, Mvb12, Vps37, and
Vps28, are highlighted.
FIGURE 4 ESCRT-0 associates stably with ubiquitin-conjugated
VAMP2. (A, C, E, and G) Representative AFM images of bilayers assem-
bled in the presence of Ub-VAMP2 and either (A) wildtype ESCRT-0,
(C) ESCRT-0 harboring point mutations in the DUIM domain of Hrs, (E)
ESCRT-0 harboring two-point mutations in the VHS and UIM domains
of STAM, or (G) ESCRT-0 harboring point mutations in all ubiquitin-bind-
ing domains. A shade-height scale bar is shown. Scale bar¼ 200 nm. (B, D,
F, and H) the frequency distributions of molecular volumes for particles
observed by AFM are shown. Each graph indicates the form of ESCRT-
0 visualized together with Ub-VAMP2.
ESCRT-0 Sequesters Ubiquitin-Modified Cargoes 81(Fig. 5, C and D). A similar downward redistribution of
particles was observed when ESCRT-I was incubated with
Ub-VAMP2 (Fig. 5, E and F). To confirm that the intact
ESCRT-I complex can bind to ubiquitin, we immobilized
GST alone or a mixture of mono- and di-ubiquitin fused
to GST on glutathione agarose beads, and incubated them
with purified ESCRT complexes (Fig. 6 A). We found that
ESCRT-I exhibited preferential binding to beads harboring
GST-tagged ubiquitin as compared with GST alone, as
observed for ESCRT-0 components (Fig. 6 B). Together,
these data strongly suggest that ESCRT-I is incapable of
binding stably to an integral membrane cargo modified
only by mono-ubiquitin.
The ESCRT-II complex acts downstream of ESCRT-I and
harbors three distinct subunits, Vps22, Vps25, and Vps36,which assemble with a 1:2:1 stoichiometry in solution.
The combined molecular mass of this complex is
116 kDa, giving an expected molecular volume of
140 nm3. The Vps36 subunit harbors a single ubiquitin in-
teracting motif within its amino terminus. Using a GST
pull-down assay, we confirmed that intact C. elegans
ESCRT-II binds directly to ubiquitin (Fig. 6 B). Further-
more, we found that ESCRT-II assembles on lipid bilayers
using AFM, exhibiting a peak molecular volume of
~200 nm3 in the presence of 54% PC, 30% PE, 15% PS,
and 1% PI3P, consistent with our previous work (24; see
also Fig. 7, A and B). The measured volume is somewhat
higher than the expected volume; nevertheless, because of
the caveats associated with volume measurement by
AFM, we suggest that the volume peak represents a single
ESCRT-II complex. In contrast to our results with
ESCRT-0, we found that neither the addition of VAMP2
or Ub-VAMP2 resulted in an upward shift in particleBiophysical Journal 108(1) 76–84
FIGURE 6 The intact, early acting ESCRT complexes bind to ubiquitin.
(A) GST alone or a mixture of GST fused to mono-ubiquitin or di-ubiquitin
was immobilized on glutathione agarose beads. Fractions of the beads were
resuspended in sample buffer following purification and separated by SDS-
PAGE. Silver staining was conducted to determine the proteins associated
with the resin. A molecular mass marker is shown in the left-most lane.
From top to bottom, the markers have masses of 75, 50, 37, 25, and
20 kDa. (B) Purified ESCRT-0, ESCRT-I, and ESCRT-II were incubated
with the beads described in panel A. Following extensive washing, beads
were eluted using reduced glutathione, and eluates were separated by
SDS-PAGE. The presence of each ESCRT complex was determined by
immunoblotting, using antibodies against ESCRT-0 (Hrs and STAM),
ESCRT-I (Mvb12), and ESCRT-II (Vps22). To determine the relative
amount of each ESCRT complex that bound specifically to GST-ubiquitin,
dilutions of the fractions that bound to GST-ubiquitin were evaluated and
compared with the total amount bound to GST alone (100%). The dilution
series enabled us to generate a standard curve, against which the amount of
protein that bound to GSTalone could be measured. In all cases, the ESCRT
complexes exhibited a preference for binding to GST-ubiquitin as compared
with GST alone.
FIGURE 7 ESCRT-II does not associate stably with VAMP2 or ubiqui-
tin-conjugated VAMP2. (A, C, and E) Representative AFM images of bila-
yers assembled in the presence of either (A) ESCRT-II alone, (C) ESCRT-II
together with VAMP2, or (E) ESCRT-II together with Ub-VAMP2. A
shade-height scale bar is shown. Scale bar¼ 200 nm. (B, D, and F) The fre-
quency distributions of molecular volumes for particles observed by AFM
are shown. Each graph indicates the proteins present in the experiment.
In panel B, a representative Coomassie stained gel of recombinant
ESCRT-II is also shown. The molecular mass markers are indicated by
dashes on the right. From top to bottom, the markers have masses of 50,
37, 25, and 20 kDa. The ESCRT-II subunits, Vps36, Vps22, and Vps25,
are highlighted.
82 Takahashi et al.volume (Fig. 7, C–F). These data indicate that ESCRT-II is
not able to bind stably to integral membrane proteins, irre-
spective of the presence of ubiquitin. Together, our findings
highlight the specific ability of ESCRT-0 to bind and
sequester integral membrane proteins in a manner depen-
dent on the presence of ubiquitin.DISCUSSION
Modification of many transmembrane proteins by ubiquitin
conjugation serves as a sorting signal for transport into the
lumen of multivesicular endosomes. Unlike proteasomal
targeting, which typically utilizes polyubiquitin chains,
conjugation of one or a few ubiquitin moieties is sufficient
for entry into ILVs (28). In mammalian cells, the E3 ubiqui-
tin ligase c-Cbl modifies several cell surface receptors,Biophysical Journal 108(1) 76–84including activated epidermal growth factor receptor, and
mutations in c-Cbl that impair its ability to ubiquitin-modify
substrates have been linked to oncogenic transformation
(29). Similarly, numerous mutations that perturb transport
through the endocytic system are also associated with can-
cer, potentially by affecting receptor degradation (30).
Together, these data underscore a need to better understand
the mechanisms that regulate ubiquitin-dependent receptor
sorting.
Mechanisms by which the ESCRT machinery handles
ubiquitin-modified cargoes have long been debated. In
one widely cited model, ESCRT-0 delivers substrates
directly to ESCRT-I and/or ESCRT-II (31). However, struc-
tural and thermodynamic studies fail to support this hand-
off scenario (32). Additionally, our data do not support the
possibility that ESCRT-0 transfers cargoes to other com-
plexes in the pathway, as neither ESCRT-I nor ESCRT-II
was capable of stably binding a mono-ubiquitin-modified
ESCRT-0 Sequesters Ubiquitin-Modified Cargoes 83substrate. Alternatively, ESCRT-0 may act as a central
nucleating factor, sequestering ubiquitin-modified cargoes
within subdomains on endosomal membranes, and subse-
quently aiding the recruitment of downstream ESCRT
complexes (12,32). In this model, eventual release
of ESCRT-0 from the site of vesicle formation would
require coordination with the internalization of cargoes
into ILVs, which may involve ubiquitin-binding domains
in ESCRT-I and/or ESCRT-II to restrict cargo diffu-
sion. Further studies are necessary to validate such a
model.
Although our studies indicate that ESCRT-II forms
individual heterotetrameric complexes on membranes,
previous work suggests that the lipid environment can in-
fluence ESCRT complex assembly. Specifically, the pres-
ence of 25 mol % cholesterol was shown to promote
ESCRT-II clustering in vitro, even in the absence of its
endogenous recruitment factor ESCRT-I (33). On average,
the presence of cholesterol caused ~50 ESCRT-II com-
plexes to coalesce on a model membrane, and these clus-
tered complexes were capable of binding to ubiquitin. This
finding is consistent with our data that numerous low-af-
finity ubiquitin-binding domains must be present to stably
recruit and sequester ubiquitin-modified cargoes. How-
ever, it remains unclear whether such a large number of
ESCRT-II complexes assemble simultaneously on the en-
dosome in vivo. Based on biochemical data and localiza-
tion studies, the majority of ESCRT-II is found in the
cytoplasm at steady state, making it an unlikely candidate
to cluster cargoes before their deposition into ILVs (34).
By contrast, ESCRT-0 binds to membranes stably, and
our data indicate that its multiple ubiquitin-binding do-
mains can bind cargo efficiently, unlike other ESCRT
complexes. Together, our findings strongly suggest that
ESCRT-0 acts upstream of ESCRT-I and ESCRT-II to
bind ubiquitin-modified cargoes during multivesicular en-
dosome biogenesis.SUPPORTING MATERIAL
Seven figures are available at http://www.biophysj.org/biophysj/
supplemental/S0006-3495(14)01185-0.
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